发明名称 DRUGS FOR AMELIORATING POSTCIBAL HYPERGLYCEMIA
摘要 <p>Agent comprises an anion exchange resin. ACTIVITY : Antidiabetic; Antilipemic. In tests, colestimide was administered at 1.5 g/day in 2 doses to a 63 year old volunteer. Total blood cholesterol levels reduced from 204 to 142 mg/dl and blood triglyceride levels reduced from 221 to 146 mg/dl over a 24 hour period. MECHANISM OF ACTION : Cholesterol-Antagonist.</p>
申请公布号 EP1413309(A1) 申请公布日期 2004.04.28
申请号 EP20020749378 申请日期 2002.07.29
申请人 MITSUBISHI PHARMA CORPORATION 发明人 OBA, KENZO
分类号 A61K31/64;A61K31/66;A61K31/785;A61K31/787;A61P3/06;A61P3/10;(IPC1-7):A61K31/787 主分类号 A61K31/64
代理机构 代理人
主权项
地址